{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-5/paragraph-25",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-5/paragraph-25.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/5/paragraph/25",
  "kind": "paragraph",
  "number": "25",
  "heading": "Inspections and access to information",
  "text": "(1) An NHS appliance contractor (C) must allow persons authorised in writing by NHS England to enter and inspect any premises C uses for the provision of pharmaceutical services at any reasonable time, for the purposes of—\n(a) ascertaining whether or not C is complying with the requirements of this Schedule;\n(b) auditing, monitoring and analysing—\n(i) the provision made by C, in the course of providing pharmaceutical services, for patient care and treatment, including any arrangement made with a person in respect of provision of appliances, and\n(ii) the management by C of the pharmaceutical services C provides,\nwhere the conditions in sub-paragraph (2) are satisfied.\n(2) The conditions are that—\n(a) reasonable notice of the intended entry has been given;\n(b) the Local Pharmaceutical Committee for the area where the premises are situated have been invited to be present at the inspection, where this is requested by C;\n(c) the person authorised in writing (X) carries written evidence of X's authorisation, which X produces on request; and\n(d) X does not enter any part of the premises used solely as residential accommodation without the consent of the resident.\n(3) C must, at the request of NHS England or of X, allow it or X access to any information which it or X reasonably requires—\n(a) for the purposes mentioned in sub-paragraph (1); or\n(b) in the case of NHS England, in connection with its functions that relate to pharmaceutical services.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/5/paragraph/25",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}